Bioresorbable
Scaffolds Market Size Research Report, by Material (absorbable magnesium stent
(AMS), polymeric scaffold, poly carbonate scaffold and others), by Types (drug
eluting coronary scaffolds, everolimus-eluting device, novolimus-eluting
device, sirolimus-eluting device, paclitaxel-eluting device), by Applications
(peripheral vascular intervention, regulation of blood flow and others) by End
Users (hospitals, clinics and others) - Global Forecast till 2023
Bioresorbable scaffolds are medical devices used
in widening clogged arteries or veins and primarily find use in cardiovascular
surgeries. They have gained prominence in recent years due to metallic
scaffolds causing an infection within the body and resulting in patient death.
Developments of bioresorbable scaffolds to reach the level of drug-eluting
stents are likely to drive the global bioresorbable scaffolds market.
Market Outlook
The global Bioresorbable Scaffolds Market Size is expected to touch a towering valuation by
exhibiting 18.9% CAGR from 2017 to 2023 (forecast period). High prevalence of cardiovascular
disorders is the primary driver of the market. According to a 2014 report by
the World Health Organization (WHO), cardiovascular diseases can account for a
majority of deaths globally. Rising rates of obesity, diabetes, and sedentary
lifestyle of patients can all contribute to the market growth.
Increasing government support and investment
for better medical techniques and breakthroughs of techniques in cardiovascular
surgeries can fuel the bioresorbable scaffolds market. Biodegradable nature of
these stents which allow for recovery of vessel vasoreactivity can play a
pivotal role in the market in the coming years. Use of polymers as a coating
for stents for providing adequate radial strength will open up new growth
avenues.
But availability of alternative therapies can
restrain market growth.
Segmentation
Analysis:
The global bioresorbable scaffolds market is
segmented by material, type, application, and end-user.
By material, it is segmented into
polycarbonate scaffold, polymeric scaffold, absorbable magnesium stent (AMS),
and others. Polymeric and polycarbonate scaffold segments can account for a
large market share due to increasing use of PCI procedures and preference of
polymer-based stents.
By type, it is segmented into
paclitaxel-eluting device, drug eluting coronary scaffolds, sirolimus-eluting
device, everolimus-eluting device, and novolimus-eluting device.
By application, it is segmented into
regulation of blood flow control, peripheral vascular intervention, and others.
By end-user, it is segmented into clinics,
hospitals, and others. Hospitals can account for a large market share due to
preference of hospitals by patients for diagnostic and surgical procedures.
Rapid rate of cardiovascular surgeries can drive the segment growth exponentially.
Browse Complete Report: https://www.marketresearchfuture.com/reports/bioresorbable-scaffolds-market-1251
Regional Analysis
Europe, the Middle East & Africa (MEA),
Asia Pacific, and the Americas are regions covered in the bioresorbable
scaffolds market report.
The Americas accounted for close to 40%
market share in 2016. Large geriatric population, large share of the regional
population plagued by obesity and diabetes, and presence of prominent market
players are factors bound to propel demand for bioresorbable scaffolds in the
region. High stress levels, lack of exercise, and deskbound lifestyle of
patients are other drivers positively impacting the bioresorbable scaffolds
market. High incidence of pulmonary artery disease, coronary artery disease,
and other diseases which can harden or weaken arteries can also be a vital
growth determinant in the market.
Europe has the second largest market share
due to a large healthcare budget, patient-friendly reimbursement policies, and
presence of developed economies of Italy, France, and Germany. Rising focus of
players in the region to focus on clinical trials of stents and rise of
pulmonary coronary interventional (PCI) procedures
The APAC region can account for the fastest
growth rate due to a large patient pool, large number of skilled surgeons, and
high incidence of cardiovascular disorders. Furthermore, reduction in prices of
stents by governments for making it affordable for patients across all economic
strata can bode well for the market within the region.
Competitive Outlook
Boston
Scientific Corporation,Kyoto Medical Planning Co. Ltd.,Translumina,Elixir
Medical Corporation,MicroPort Scientific Corporation,Xenogenics Corporation,B.
Braun,TERUMO CORPORATION,Biotronik,Abbott,Amaranth Medical, Inc.,Medtronic,REVA
Medical, Inc,Cardinal Health., and Lombard Medical, Inc, are some of the
noteworthy players in the global bioresorbable scaffolds market.
No comments:
Post a Comment